On Wednesday, The Western Union Company (NYSE:WU)’s shares declined -1.35% to $21.14.
The Western Union Company (WU) a leader in global payment services, and MasterCard (MA) today formalized a deal that will enable remittances originated from nearly anywhere across the globe to be received on Maestro and MasterCard consumer cards using automated teller machines (ATMs) across Romania, one of the largest remittance receivers in Eastern Europei.
An innovative tripartite agreement between Western Union, MasterCard and Banca Transilvania (BT) will provide the choice to millions of cardholders to withdraw international remittances from over 900 BT owned ATMs in Romania. The service is expected to be activated later this year.
An innovative tripartite agreement between Western Union, MasterCard and Banca Transilvania (BT) will provide the choice to millions of cardholders to withdraw international remittances from over 900 BT owned ATMs in Romania. The service is predictable to be activated later this year.
The initiative realizes Western Union’s strategy in giving customers choice; while adding to the company’s growing foray in directing global remittances into account-based channels.
The Western Union Company provides money movement and payment services worldwide. The company operates in three segments: Consumer-to-Consumer, Consumer-to-Business, and Business Solutions. The Consumer-to-Consumer segment offers cash money transfer services involving walk-in agent locations. This segment provides various options for sending and receiving funds, counting walk-in and telephone money transfer, online money transfer, and account based money transfer services through a network of third-party agents using multi-currency and real-time money transfer processing systems.
Target Corporation (NYSE:TGT)’s shares dropped -0.50% to $84.34.
CVS Health Corporation (CVS) and Target Corporation (TGT) declared recently that they have reached a definitive agreement for CVS Health to acquire Target’s pharmacy and clinic businesses for about $1.9 billion. Through this agreement, CVS Health will acquire Target’s more than 1,660 pharmacies across 47 states and operate them through a store-within-a-store format, branded as CVS/pharmacy. In addition, a CVS/pharmacy will be comprised of in all new Target stores that offer pharmacy services. Target’s nearly 80 clinic locations will be rebranded as MinuteClinic, and CVS Health will open up to 20 new clinics in Target stores within three years of the close of the transaction. The new clinics will be part of CVS/minuteclinic’s plan to operate 1,500 clinics by 2017. In addition, CVS Health and Target plan to develop five to 10 small, flexible format stores over a two-year period following the deal close, which will each be branded as TargetExpress and comprise a CVS/pharmacy.
This planned relationship brings together two leading retailers with complementary strengths, brands and cultures to enhance the health care experience for Target guests while expanding CVS Health’s retail presence in new markets, such as Seattle, Denver, Portland and Salt Lake City. The transaction enables CVS Health to reach more patients, adding a new retail channel for its offerings, and expanding convenient options for consumers. Given CVS Health’s proven success in growing its business, the relationship is predictable to benefit Target’s long-term traffic and sales growth. It also enables Target to strengthen its focus on wellness as a signature category. Moving forward, improved efforts by Target will center on ongoing to deliver products and experiences to assist guests eat well, be active and find natural and clean label products.
Target Corporation operates as a general merchandise retailer in the United States and Canada. It offers household essentials, counting pharmacy, beauty, personal care, baby care, cleaning, and paper products; music, movies, books, computer software, sporting goods, and toys; electronics, such as video game hardware and software; and apparel for women, men, boys, girls, toddlers, infants, and newborns, in addition to intimate apparel, jewelry, accessories, and shoes.
At the end of Wednesday’s trade, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA )‘s shares dipped -0.74% to $59.37.
, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) resource designed to assist healthcare professionals and people affected by pain navigate the complex pain care landscape. Pain affects more Americans than diabetes, heart disease and cancer combined and while prescription pain medications are an important component of pain administration, the reality is these products are prone to abuse and misuse. A new survey conducted on behalf of Teva in partnershipwith the American Academy of Pain Administration and U.S. Pain Foundation broadly found:
- Healthcare professionals and people affected by pain recognize their personal responsibility in addressing prescription drug abuse;
- Some healthcare professionals and people affected by pain are uncomfortable talking with each other about the issue;
- They also agree information and resources are critical in assisting address prescription drug abuse.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers generic or branded generic medicines; specialized products, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances; and active pharmaceutical ingredients.
Paragon Offshore PLC (NYSE:PGN), ended its Wednesday’s trading session with -7.94% loss, and closed at $1.16.
Paragon Offshore PLC (PGN) declared that it has reached a sale-leaseback agreement, worth $300 million, with SinoEnergy Corp., a British Virgin Islands registered private investment company.
Per the deal, Paragon Offshore is predictable to sell two of its heavy duty jack-up rigs – capable of operating in a harsh environment – and will simultaneously lease the units back for a period of five years. The company added that the fund from the sale should boost its liquidity and be utilized for reducing debt.
After deducting fees and expenses, Paragon Offshore will likely get $292 million from the divestment – implying Paragon Offshore’s intention to free up cash especially in the unfavorable oil pricing environment.
It is to be noted, that through Nov 2016, the dayrate for one rig is $71,000. For the remaining period of the rig’s charter, the dayrate is anticipated to come down to $42,000 each day. Moreover, the other jackup’s initial day rate per day will likely be $71,000 through Feb 2018. After that, the rate will decrease to $42,000 for the remaining period.
Paragon Offshore plc, together with its auxiliaries, provides offshore drilling rigs. The company is involved in contracting its rigs, related equipment, and work crews to conduct oil and gas drilling and workover operations for its exploration and production customers on a day rate basis. Its drilling fleet comprises of 34 jackups and 6 floaters, counting 4 drillships and 2 semisubmersibles.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
